Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
about
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapyIdentification of glycogen synthase kinase 3α as a therapeutic target in melanomaGSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancerInsights into the interactions between maleimide derivates and GSK3β combining molecular docking and QSARDiscrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis.KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer.Glycogen synthase kinase-3: a potential preventive target for prostate cancer managementSerpine2, a potential novel target for combating melanoma metastasisHyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone.Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?Pro-oxidant treatment of human prostate carcinoma (DU145) induces autoschizis cell death: autophagosomes build up out of injured endomembranes and mitochondria.Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.Unraveling the role of Arg4 and Arg6 in the auto-inhibition mechanism of GSK3β from molecular dynamics simulation.Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells.Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer
P2860
Q26739711-428A07C0-25EA-416C-986F-2E34B666F5A1Q33569998-59654460-453E-4F70-BE5D-EC13D000A5C7Q34216085-89C68D6A-37BB-4695-85F5-6E2624CD4406Q34483490-A8173379-16A3-40C4-BC5D-12CA7368B93DQ35204391-F44939E1-5EF6-47F7-971B-084E87267AA8Q35742439-2DCC8514-3349-4650-B4B8-3ABBF4D05F47Q35856215-26C33827-6B19-4D2F-8BB0-9FE71203C862Q35980822-395CD186-9F1D-45D9-BA4E-7AF84A4743A9Q36580561-A11AC593-0CEA-4A23-B861-0C23C948D6EDQ36964051-717F485A-45BF-465C-9937-E1BE2A8CFF16Q37046424-93695202-0611-4FA2-B8C7-7DDADFFFE819Q37407566-A19C0C54-F4EC-4D1E-9785-71E76919611FQ37718461-A632896B-5A65-4ADB-9DF7-05201553A02FQ38272835-A83917D3-C9F3-4406-A311-B097E5BD725CQ38719143-D6EDD5A5-0E24-4914-A27D-33E9744D09DAQ38944664-689AB830-C14A-4636-8044-E209AF09A4FAQ38982040-D96B4A39-3073-4302-8EA9-ABC7698295C1Q50590583-1628B0AD-9E12-4CEB-A4CC-FED8B8F2F96AQ54383410-E35DA1B3-130E-4EF9-AFD3-8F198B859BCFQ54936181-3A217C01-52D4-438C-8215-987D6947E25CQ58572626-AC579F07-5A04-4171-8FE8-A0DC98DAF715
P2860
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@en
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@nl
type
label
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@en
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@nl
prefLabel
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@en
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
@en
P2093
Irantzu Gorrono-Etxebarria
Jonathan Waxman
Marjorie M Walker
Pinar Uysal-Onganer
R Siobhan Darrington
Yoshiaki Kawano
P2860
P304
P356
10.1002/IJC.27620
P577
2012-05-22T00:00:00Z